Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1).

In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system for integrated care with organizational health literacy. MASK (Mobile Airways Sentinel NetworK) (1), a new development of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health) (2), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life integrated care pathways (ICPs) (3)-centred around the patient with rhinitis and using mHealth monitoring of environmental exposure (4).

[1]  A. Sheikh,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. , 2019, The Journal of allergy and clinical immunology.

[2]  P. Gergen,et al.  Rhinitis in children and adolescents with asthma: Ubiquitous, difficult to control, and associated with asthma outcomes , 2019, The Journal of allergy and clinical immunology.

[3]  D. Campbell-Lendrum,et al.  Environmental risks and non-communicable diseases , 2019, BMJ.

[4]  D. Campbell-Lendrum,et al.  Climate change, air pollution and noncommunicable diseases , 2018, Bulletin of the World Health Organization.

[5]  V. Jormanainen.  Large-scale implementation and adoption of the Finnish national Kanta services in 2010–2017: a prospective, longitudinal, indicator-based study , 2018, Finnish Journal of eHealth and eWelfare.

[6]  T. To,et al.  Country activities of Global Alliance against Chronic Respiratory Diseases (GARD): focus presentations at the 11th GARD General Meeting, Brussels. , 2018, Journal of thoracic disease.

[7]  Rosalind W. Picard,et al.  MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence , 2018, Clinical and Translational Allergy.

[8]  Daniel Laune,et al.  POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project , 2018, Clinical and Translational Allergy.

[9]  J. Bousquet,et al.  Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber. , 2018, The journal of allergy and clinical immunology. In practice.

[10]  A. Sheikh,et al.  Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study , 2018, Allergy. European Journal of Allergy and Clinical Immunology.

[11]  J. Bousquet,et al.  Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management , 2018, Clinical and Translational Allergy.

[12]  A. Sheikh,et al.  The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study , 2018, Allergy.

[13]  J. Bousquet,et al.  European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017) , 2017, Clinical and Translational Allergy.

[14]  A. Sheikh,et al.  CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report , 2017, Clinical and Translational Allergy.

[15]  Joaquim Mullol,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision , 2017, The Journal of allergy and clinical immunology.

[16]  J. Bousquet,et al.  Work productivity in rhinitis using cell phones: The MASK pilot study , 2017, Allergy.

[17]  O. Mayora,et al.  Validation of the MASK‐rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  A. Sheikh,et al.  The Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire Using Mobile Technology: The MASK Study. , 2017, Journal of investigational allergology & clinical immunology.

[19]  J. Bousquet,et al.  The Finnish Allergy Programme 2008–2018 works , 2017, European Respiratory Journal.

[20]  P Demoly,et al.  Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK‐rhinitis study , 2017, Allergy.

[21]  T. Haahtela,et al.  The Finnish experience to save asthma costs by improving care in 1987‐2013 , 2017, The Journal of allergy and clinical immunology.

[22]  Todor A Popov,et al.  ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle , 2016, Clinical and Translational Allergy.

[23]  P. Gergen,et al.  Pathways through which asthma risk factors contribute to asthma severity in inner-city children. , 2016, The Journal of allergy and clinical immunology.

[24]  P. Gergen,et al.  Asthma phenotypes in inner-city children. , 2016, The Journal of allergy and clinical immunology.

[25]  P. Gergen,et al.  Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents. , 2016, The Journal of allergy and clinical immunology.

[26]  Erle C. Ellis,et al.  The Anthropocene is functionally and stratigraphically distinct from the Holocene , 2016, Science.

[27]  Subhrendu K. Pattanayak,et al.  Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation–Lancet Commission on planetary health , 2015, The Lancet.

[28]  D. Postma,et al.  Integrated care pathways for airway diseases (AIRWAYS-ICPs) , 2014, European Respiratory Journal.

[29]  M. Sofiev,et al.  A numerical model of birch pollen emission and dispersion in the atmosphere. Description of the emission module , 2012, International Journal of Biometeorology.

[30]  V. Kinnula,et al.  The 10-year COPD Programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortality. , 2011, Primary care respiratory journal : journal of the General Practice Airways Group.

[31]  P. Jousilahti,et al.  No increase in the prevalence of COPD in two decades , 2010, European Respiratory Journal.

[32]  J. Bourbeau,et al.  Promoting effective self-management programmes to improve COPD , 2009, European Respiratory Journal.

[33]  S. Dinneen.  Structured education for people with type 2 diabetes , 2008, BMJ : British Medical Journal.

[34]  M Kaila,et al.  A 10 year asthma programme in Finland: major change for the better , 2006, Thorax.

[35]  Michael J. Hensley,et al.  Sleep apnoea. , 2003, Clinical evidence.

[36]  V. Jormanainen.  [Introduction of Kanta services between 2010 and 2014]. , 2015, Duodecim; laaketieteellinen aikakauskirja.